Targeting ferroptosis in hepatocellular carcinoma

被引:14
|
作者
Mo, Yuqian [1 ]
Zou, Zhilin [2 ]
Chen, Erbao [3 ]
机构
[1] Guangdong Med Univ, Sch Publ Hlth, Zhanjiang 524023, Guangdong, Peoples R China
[2] Wenzhou Med Univ, Affiliated Eye Hosp, Dept Ophthalmol, Wenzhou, Zhejiang, Peoples R China
[3] Peking Univ, Shenzhen Hosp, Dept Hepatobiliary & Pancreat Surg, Shenzhen 518036, Guangdong, Peoples R China
关键词
Ferroptosis; Hepatocellular carcinoma; Immunotherapy; Immune microenvironment; SUPPRESSOR-CELLS; LIPID-PEROXIDATION; T-CELLS; 1ST-LINE TREATMENT; CANCER; DYSFUNCTION; SORAFENIB; ZIP14; TRANSPORTER; SENSITIVITY;
D O I
10.1007/s12072-023-10593-y
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Hepatocellular carcinoma (HCC) is a common malignant tumor with complex survival mechanism and drug resistance, resulting in cancer-related high mortality in the world. Ferroptosis represents a form of regulated cell death, typically distinguished by iron-dependent lipid peroxidation. Cancer cells often employ antioxidant defenses to evade the harmful effects of excess iron. Recent research has proposed that directing interventions towards ferroptosis could serve as an effective strategy in curbing the proliferation and invasion of HCC. Immunotherapy has made some preliminary progress in the remodeling of immune microenvironment, but it has not completely inhibited HCC growth, invasion and drug resistance. Furthermore, ferroptosis is widely observed in the formation of immune microenvironment of HCC and mediates the response of many targeted drugs and immunotherapy. Clarifying the role of ferroptosis in these complex processes is expected to provide a new prospect for HCC treatment. In this review, we outline the mechanisms by which HCC develops invasiveness and drug resistance by evading iron-dependent death, and paint a comprehensive landscape of ferroptosis in different cell types in the HCC immune microenvironment.
引用
收藏
页码:32 / 49
页数:18
相关论文
共 50 条
  • [1] Targeting ferroptosis in hepatocellular carcinoma
    Yuqian Mo
    Zhilin Zou
    Erbao Chen
    Hepatology International, 2024, 18 : 32 - 49
  • [2] Perspectives and mechanisms for targeting ferroptosis in the treatment of hepatocellular carcinoma
    Li, Lanqing
    Wang, Xiaoqiang
    Xu, Haiying
    Liu, Xianqiong
    Xu, Kang
    FRONTIERS IN MOLECULAR BIOSCIENCES, 2022, 9
  • [3] Targeting Hepatocellular Carcinoma: Schisandrin A Triggers Mitochondrial Disruption and Ferroptosis
    He, Lin-wei
    Lin, Chang-jie
    Zhuang, Lin-jun
    Sun, Yi-hui
    Li, Ye-cheng
    Ye, Zhen-yu
    CHEMICAL BIOLOGY & DRUG DESIGN, 2024, 104 (06)
  • [4] Targeting ferroptosis in hepatocellular carcinoma (vol 18, pg 32, 2024)
    Mo, Yuqian
    Zou, Zhilin
    Chen, Erbao
    HEPATOLOGY INTERNATIONAL, 2024, 18 (03) : 1065 - 1065
  • [5] Targeting cell death mechanisms: the potential of autophagy and ferroptosis in hepatocellular carcinoma therapy
    Liu, Beibei
    Liu, Ling
    Liu, Yang
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [6] Role of ferroptosis in hepatocellular carcinoma
    Nie, Jianhua
    Lin, Binlin
    Zhou, Meng
    Wu, Li
    Zheng, Tongsen
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2018, 144 (12) : 2329 - 2337
  • [7] Role of ferroptosis in hepatocellular carcinoma
    Jianhua Nie
    Binlin Lin
    Meng Zhou
    Li Wu
    Tongsen Zheng
    Journal of Cancer Research and Clinical Oncology, 2018, 144 : 2329 - 2337
  • [8] Brusatol induces ferroptosis to inhibit hepatocellular carcinoma progression by targeting ATF3
    Wan, Yuanyuan
    Cheng, Jingsong
    Gan, Debiao
    He, Jiaming
    Chen, An
    Ma, Jing
    Li, Yunying
    Wang, Xiao
    Ran, Jianhua
    Chen, Dilong
    Li, Jing
    CHEMICAL BIOLOGY & DRUG DESIGN, 2024, 103 (06)
  • [9] Pharmacological targeting of the mitochondrial phosphatase PTPMT1 sensitizes hepatocellular carcinoma to ferroptosis
    Li, Miaomiao
    Wang, Yi
    Li, Xinyan
    Xu, Jiayi
    Yan, Liangwen
    Tang, Shenkang
    Liu, Chenyue
    Shi, Mengjiao
    Liu, Rongrong
    Zhao, Yaping
    Zhang, Yi
    Yang, Lan
    Zhang, Yinggang
    Wang, Gang
    Li, Zongfang
    Guo, Ying
    Feng, Yetong
    Liu, Pengfei
    CELL DEATH & DISEASE, 2025, 16 (01):
  • [10] Targeting fatty acid synthase modulates sensitivity of hepatocellular carcinoma to sorafenib via ferroptosis
    Li, Yan
    Yang, Wenjuan
    Zheng, Yuanyuan
    Dai, Weiqi
    Ji, Jie
    Wu, Liwei
    Cheng, Ziqi
    Zhang, Jie
    Li, Jingjing
    Xu, Xuanfu
    Wu, Jianye
    Yang, Mingwei
    Feng, Jiao
    Guo, Chuanyong
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2023, 42 (01)